Global Minimally Invasive Neurosurgical Devices Market is valued at approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Minimally invasive neurosurgical devices are those utilized in neurosurgery. With the aid of this device, healing time is quickened, and the size of the required incision is constrained. These instruments are frequently created and used by neurosurgery specialists and are normally relatively small for extremely precise surgeries. Minimally invasive neurosurgical devices are any less traumatic method than open surgery used for the same purpose, and they are redefining surgery. In minimally invasive neurosurgery (MIS) procedures, which assess the operating field on a micro- or endoscopic scale, laparoscopic equipment and remote controls for surgical tools are routinely used. The increasing prevalence of neurological disorders and growing geriatric population are key factors driving the market growth.

As the world’s population ages and more neurological illnesses are diagnosed, the cost of mortality and impairment brought on by these conditions is being increasingly acknowledged as a worldwide public health concern. For instance – as per Pan American Health Organization (PAHO) – in 2019 people died because of neurological disorders accounted for 533,172, with 320,043 (60%) women and 213,129 (40%) men. Age-standardized mortality rates were 32.9 per 100,000 people, with 33.1 deaths per 100,000 people for males and 32.2 for women. The United States of America has the highest age-standardized death rate (47.4 deaths per 100,000 people), while Venezuela has the lowest rate (6.6 deaths per 100,000 population). Furthermore, according to the World Bank Group, the world’s old population was 727 million in 2020, and it is predicted to treble over the next three decades, reaching 1.5 billion in 2050. Also, increasing incidence of vascular disorders increases and growing number of neurosurgical procedures would create a lucrative growth prospectus for the market over the forecast period. However, the high cost of Minimally Invasive Neurosurgical Devices and procedures stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Minimally Invasive Neurosurgical Devices Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the rising prevalence of neurovascular diseases and also the growing awareness among neurosurgeons and doctors regarding the benefits of these neurology devices. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, increasing prevalence of neurological conditions as well as growing expansion of healthcare services in the region.

Major market players included in this report are:
General Medical Inc.
Stryker
Zimmer Biomet
B. Braun Melsungen AG
Olympus Corporation
Renishaw Plc.
Medtronic
Danaher
Zeiss
Karl Storz SE & Co. KG

Recent Developments in the Market:
? In September 2022, Brainlab announced the acquisition of Waldkrich, Germany based Dr. Langer Medical GmbH. The family-owned company specializes in the development of intraoperative neuromonitoring solutions and related equipment for surgical interventions.


Global Minimally Invasive Neurosurgical Devices Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product, Surgery Type, End-Use, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*


The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product
Surgical Devices
Monitoring and Visualization Devices
Endoscopy Devices

By Surgery Type
Endonasal Neurosurgery
Intracranial
Spinal Surgery

By End-Use
Hospital & Clinics
Medical Institution
Ambulatory Surgical Center

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World